BB BIOTECH AG

Q4 2023 13F Notice

Signature - Title
Martin Gubler / Ivo Betschart - SIGNING AUTHORITY
Location
Schaffhausen
Holdings as of
December 31, 2023
Date filed
2/14/2024, 12:17 PM
Description
No holdings are reported in this report, and all US holdings are reported by other reporting manager(s). The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q1 2019 - May 13, 2019

BB BIOTECH AG didn't report any stock holdings as of Q4 2023.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Martin Gubler / Ivo Betschart SIGNING AUTHORITY Kuesnacht, Switzerland 2/12/2024

Bellevue Group AG is reporting for BB BIOTECH AG:

Name Holdings Value Location File Number
Bellevue Group AG $6.17B Kuesnacht, Switzerland 028-17462